NextCure  Inc (NXTC) — Capital Reinvestment Ratio

Latest as of December 2018: 0.08x

NextCure  Inc (NXTC) has a Capital Reinvestment Ratio of 0.08x as of December 2018, meaning it reinvests 0% of its operating cash flow ($22.47 Million) in capital expenditures ($1.90 Million). Check NextCure  Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

$22.47 Million
USD

Capital Expenditures

$1.90 Million
USD

Data as of

Dec 2018
Most recent filing

NextCure  Inc Capital Reinvestment Ratio (2018–2018)

This chart tracks NextCure  Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see NXTC cash flow conversion.

Annual Capital Reinvestment Ratio for NextCure  Inc (2018–2018)

Year-by-year Capital Reinvestment Ratio for NextCure  Inc from 2018 to 2018. See NXTC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2018 0.38x $7.99 Million $3.06 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow